Refractory Ventricular Tachycardia Clinical Trial
Official title:
PrOsPective Cohort Study for STereotactic Arhythmia Radioablation (STAR) of Refractory Ventricular Tachycardia
This is a multicenter, interventional study. The study will enroll patients that fulfill the inclusion criteria over a 33-month period. Considering the small number of patients who will meet the study criteria, it is also possible to include retrospective patients who already underwent STAR (for instance, as part of a compassionate program) if they meet all the inclusion and exclusion criteria as well as the treatment planning standardized requirements and sign their consent to this trial. All patients prospectively enrolled will undergo a flow of investigations following a standardized approach. ICD programming will be standardized.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04066517 -
STereotactic RadioAblation by Multimodal Imaging for VT (STRA-MI-VT)
|
N/A | |
Not yet recruiting |
NCT05337241 -
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
|
N/A | |
Not yet recruiting |
NCT02646501 -
Prospective Randomized Clinical Trial for Effect of Stellate Ganglion Block in Medically Refractory Ventricular Tachycardia
|
N/A | |
Completed |
NCT03349892 -
Stereotactic Ablative Radiotherapy for Refractory Ventricular Tachycardia
|
N/A |